Luo Lih-Fen Holding Co., Ltd. AI Stock Analysis
Luo Lih-Fen Holding Co., Ltd. (6666) AI Stock Analysis
Luo Lih-Fen Holding Co., Ltd.
(TWSE:6666)
Strong financial performance, led by an ultra-conservative balance sheet, and attractive valuation are the primary positives. Weak technical momentum from price action below moving averages and negative MACD limits the score.
Luo Lih-Fen Holding Co., Ltd. (6666) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 1.93B
- Dividend Yield
- 4.83%
- Average Volume (3M)
- 30.37K
- Price to Earnings (P/E)
- 12.3
- Beta (1Y)
- 0.46
- Revenue Growth
- 7.96%
- EPS Growth
- 39.74%
- Country
- TW
- Employees
- 547
- Sector
- General
- Sector Strength
- 55
- Industry
- Household & Personal Products
Luo Lih-Fen Holding Co., Ltd. Business Overview & Revenue Model
Company Description
Luo Lih-Fen Holding Co., Ltd. specializes in the research, development, production, and distribution of facial beauty and cosmetic products, primarily targeting the market in Mainland China. The company offers a diverse portfolio of beauty and wellne...
Luo Lih-Fen Holding Co., Ltd. Financial Statement Overview
Summary
Strong balance sheet (89) with minimal debt-to-equity of 0.03, solid income statement trends (76) showing margin expansion, and positive cash flow generation (71) despite some volatility.
Income Statement
76PositiveBalance Sheet
89Very PositiveCash Flow
71Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.18B | 1.11B | 1.13B | 971.05M | 865.51M | 916.87M |
| Gross Profit | 796.50M | 728.66M | 703.40M | 601.01M | 523.01M | 533.89M |
| EBITDA | 215.17M | 182.58M | 204.63M | 173.75M | 155.56M | 153.77M |
| Net Income | 161.44M | 114.73M | 80.73M | 88.23M | 54.81M | 70.24M |
Balance Sheet | ||||||
| Total Assets | 2.56B | 2.31B | 2.25B | 2.13B | 2.13B | 2.01B |
| Cash, Cash Equivalents and Short-Term Investments | 841.28M | 799.61M | 918.42M | 1.01B | 1.19B | 1.08B |
| Total Debt | 47.61M | 52.72M | 67.85M | 109.98M | 239.78M | 142.42M |
| Total Liabilities | 711.72M | 581.03M | 539.34M | 493.88M | 522.41M | 401.89M |
| Stockholders Equity | 1.82B | 1.70B | 1.68B | 1.60B | 1.60B | 1.60B |
Cash Flow | ||||||
| Free Cash Flow | 251.54M | 157.21M | 308.86M | 88.77M | 101.83M | -120.33M |
| Operating Cash Flow | 273.88M | 183.01M | 337.53M | 142.25M | 205.51M | 225.65M |
| Investing Cash Flow | -278.63M | -292.69M | -266.69M | -55.21M | -87.92M | -259.40M |
| Financing Cash Flow | -102.15M | -109.94M | -106.27M | -177.76M | 27.70M | -74.21M |
Luo Lih-Fen Holding Co., Ltd. Peers Comparison
Overall Rating
TW:491172Outperform
TW:290168Neutral
TW:666667Neutral
TW:129559Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | TWD 1.74B | 18.66 | ― | 4.66% | -26.73% | -34.96% | |
| 68Neutral | TWD 1.80B | 56.59 | ― | 1.50% | 1.66% | 24.15% | |
| 67Neutral | TWD 1.93B | 12.30 | ― | 4.83% | 7.96% | 39.74% | |
| 59Neutral | TWD 1.58B | 10.17 | ― | 7.14% | -5.28% | -27.33% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6666 | Luo Lih-Fen Holding Co., Ltd. | 40.75 | -5.90 | -12.65% | |
| TW:1295 | Synbio Tech Inc | 42.00 | -49.65 | -54.17% | |
| TW:2901 | Shin Shin Co. Ltd. | 24.80 | 0.30 | 1.20% | |
| TW:2942 | Jing-Jan Retail Business Co., Ltd. | 34.50 | 6.18 | 21.83% | |
| TW:4911 | G&E Herbal Biotechnology Co., Ltd. | 25.95 | -17.47 | -40.23% | |
| TW:7888 | Libo Pharma Corp. | 24.30 | -20.85 | -46.18% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
